Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.

about

Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.

Item

http://www.wikidata.org/entity/Q47328465

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.

@en

Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.

@nl

type

Item

label

Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.

@en

Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.

@nl

prefLabel

Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.

@en

Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.

@nl

P1476

Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.

@en

P2093

Chunxia Liu

http://www.w3.org/2001/XMLSchema#string

Jindong Chen

http://www.w3.org/2001/XMLSchema#string

Kang Tian

http://www.w3.org/2001/XMLSchema#string

Ke Tang

http://www.w3.org/2001/XMLSchema#string

Yan Chen

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

Zhiqiang Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells

Selective Aurora Kinase Inhibitors Identified Using a Taxol-Induced Checkpoint Sensitivity Screen

AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol.

Raf kinase as a target for anticancer therapeutics

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load.

Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK

In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells.

Molecular effects of paclitaxel: myths and reality (a critical review).

The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.

P304

2373-2383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2017.8179

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29207185

http://www.w3.org/2001/XMLSchema#string

P932

5783483

http://www.w3.org/2001/XMLSchema#string